The weekly litigation news digest is live. Subscribe now

IP Verse

Swedish Orphan Biovitrum competitive analysis

Loading summary...

Latest oppositions filed by Swedish Orphan Biovitrum

Explore patent oppositions filed by Swedish Orphan Biovitrum against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3564267
Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityCSL BEHRINGDec 17, 2021
EP3225233
Sodium Chloride Solution For Drug Reconstitution Or DilutionWYETHMay 14, 2020
EP2256135
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation FactorCSL BEHRINGDec 13, 2019

Latest PTAB cases involving Swedish Orphan Biovitrum

Discover the latest PTAB cases involving Swedish Orphan Biovitrum, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Swedish Orphan Biovitrum with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOVERATIV THERAPEUTICS33 - 2
CSL BEHRING394 -